Receptor News and Research

RSS
Breast milk components show potent in vitro SARS-CoV-2 inhibition

Breast milk components show potent in vitro SARS-CoV-2 inhibition

UB-612 vaccine booster found to elicit high neutralizing antibody levels against SARS-CoV-2 Omicron

UB-612 vaccine booster found to elicit high neutralizing antibody levels against SARS-CoV-2 Omicron

Study evaluates humoral and cellular immune memory induced by different COVID-19 vaccines

Study evaluates humoral and cellular immune memory induced by different COVID-19 vaccines

New SARS-CoV-2 Omicron-Delta recombinant virus identified in the US

New SARS-CoV-2 Omicron-Delta recombinant virus identified in the US

Study evaluates mutation-induced SARS-CoV-2 spike protein fold stability

Study evaluates mutation-induced SARS-CoV-2 spike protein fold stability

Study finds fractionation of sulfated galactan from red alga can isolate its anti-SARS-CoV-2 properties

Study finds fractionation of sulfated galactan from red alga can isolate its anti-SARS-CoV-2 properties

Anti-spike SARS-CoV-2 antibody titer trends over 15 months in healthcare workers in Boston

Anti-spike SARS-CoV-2 antibody titer trends over 15 months in healthcare workers in Boston

Uptake of SARS-CoV-2 spike protein in human cerebrovascular cells

Uptake of SARS-CoV-2 spike protein in human cerebrovascular cells

Non-hormonal male contraceptive effectively prevents pregnancy in mice

Non-hormonal male contraceptive effectively prevents pregnancy in mice

Mineralocorticoid receptor antagonist use linked to improved renal prognosis in CKD patients

Mineralocorticoid receptor antagonist use linked to improved renal prognosis in CKD patients

Niacin limits Alzheimer's disease progression in animal model

Niacin limits Alzheimer's disease progression in animal model

T-cell and neutralizing antibody response after a third COVID-19 vaccine dose in hemodialysis patients

T-cell and neutralizing antibody response after a third COVID-19 vaccine dose in hemodialysis patients

Researchers investigate Galectin-9 as a new treatment target for COVID-19

Researchers investigate Galectin-9 as a new treatment target for COVID-19

Study confirms no preexisting B-cell immunity against SARS-CoV-2 in pre-pandemic samples

Study confirms no preexisting B-cell immunity against SARS-CoV-2 in pre-pandemic samples

Recombinant SARS-CoV-2 Delta-Omicron variant identified in the United States

Recombinant SARS-CoV-2 Delta-Omicron variant identified in the United States

Monoclonal antibodies found to prevent lung inflammation in SARS-CoV-2-Omicron-infected mice

Monoclonal antibodies found to prevent lung inflammation in SARS-CoV-2-Omicron-infected mice

Study discovers potent and selective human monoclonal antibodies against Omicron variant of SARS-CoV-2

Study discovers potent and selective human monoclonal antibodies against Omicron variant of SARS-CoV-2

Umbrella analysis of the effect of renin-angiotensin-aldosterone system inhibitors on COVID-19 related outcomes

Umbrella analysis of the effect of renin-angiotensin-aldosterone system inhibitors on COVID-19 related outcomes

Novel monoclonal antibody found to have substantial neutralizing capacity against SARS-CoV-2 Omicron variant

Novel monoclonal antibody found to have substantial neutralizing capacity against SARS-CoV-2 Omicron variant

Study investigates germinal center of antibody-mediated immunity against SARS-CoV-2

Study investigates germinal center of antibody-mediated immunity against SARS-CoV-2

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.